NL-OMON36990
Completed
Not Applicable
Ex vivo clot lysis measurements in blood samples of healthy volunteers. - ROTEM-LYSIS study
Overview
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 15
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational invasive
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Healthy volunteers aged 18\-40 years.
Exclusion Criteria
- •anticoagulant or antiplatelet medication, pregnancy, history of hematologic disorders, history of deep venous thrombosis of pulmonary embolism
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Prospective study about blood clotting ability abnormality and the deep vein thrombosis in the COPDCOPDJPRN-UMIN000019233Shizuoka General Hospital, The faculty of Respiratory Medicine75
Active, not recruiting
Phase 1
This is an international, multicentre study to determine if a specific drug, which dissolves blood clots elsewhere in the body, helps improve patients with blood clots in the spaces in the brain by rapidly removing the clot when compared to placebo (a fluid that does not dissolve clots).EUCTR2008-006916-39-GBJohns Hopkins University500
Active, not recruiting
Not Applicable
Clot lysis: evaluating accelerated resolution of intraventricular hemorrhage Phase III - CLEAR IIIIntraventricular haemorrhageMedDRA version: 13.1Level: PTClassification code 10022840Term: Intraventricular haemorrhageSystem Organ Class: 10029205 - Nervous system disordersEUCTR2008-006916-39-HUJohns Hopkins University (Prof. Daniel Daniel F. Hanley, MD)500
Active, not recruiting
Phase 1
This is an international, multicentre study to determine if a specific drug, which dissolves blood clots elsewhere in the body, helps improve patients with blood clots in the spaces in the brain by rapidly removing the clot when compared to a placebo (a fluid that does not dissolve clots).Intraventricular haemorrhageMedDRA version: 14.1Level: PTClassification code 10022840Term: Intraventricular haemorrhageSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2008-006916-39-DEJohns Hopkins University500
Active, not recruiting
Phase 1
CLEAR III. Clot lysis: evaluating accelerated resolution of intraventricular hemorrhage - CLEAR IIIEUCTR2008-006916-39-ESJohns Hopkins University180